| Medical Cannabis for Gilles de la Tourette Syndrome: An Open‐Label Prospective Study S Anis, C Zalomek, AD Korczyn, A Rosenberg, N Giladi, T Gurevich Behavioural Neurology 2022 (1), 5141773, 2022 | 20 | 2022 |
| TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study A Watad, D McGonagle, S Anis, R Carmeli, AD Cohen, AM Tsur, ... Pharmacological Research 182, 106325, 2022 | 18 | 2022 |
| Vitamin D insufficiency is associated with higher incidence of dementia, a large community-based retrospective cohort study D Kiderman, N Ben-Shabat, AM Tsur, S Anis, A Watad, AD Cohen, Z Paz, ... Journal of Geriatric Psychiatry and Neurology 36 (6), 511-518, 2023 | 8 | 2023 |
| Clinical correlates and electroencephalographic features of FIRDA in a tertiary center Y Mina, F Fahoum, S Abramovici, S Anis, S Kipervasser Acta Neurologica Scandinavica 140 (6), 405-413, 2019 | 6 | 2019 |
| Adult-onset Alexander disease among patients of Jewish Syrian descent S Anis, T Fay-Karmon, S Lassman, F Shbat, O Lesman-Segev, N Mor, ... neurogenetics 24 (4), 303-310, 2023 | 4 | 2023 |
| Long-term safety of medical cannabis in Parkinson's disease: A retrospective case-control study T Goldberg, Y Redlich, D Yogev, T Fay-Karmon, S Hassin-Baer, S Anis Parkinsonism & Related Disorders 112, 105406, 2023 | 4 | 2023 |
| A single-center real-life study on the use of medical cannabis in patients with dystonia S Anis, A Faust-Socher, D Sverdlov, S Lassman, N Hezi, O Anis, G Leor, ... Frontiers in Neurology 14, 1218300, 2023 | 4 | 2023 |
| Isolated recurrent myelitis in a persistent MOG positive patient S Anis, K Regev, SJ Pittock, EP Flanagan, Y Alcalay, A Gadoth Multiple Sclerosis and Related Disorders 30, 163-164, 2019 | 4 | 2019 |
| Rituximab as a Second-Line Treatment for Lymphocytic Vasculitis of the Central Nervous System. S Anis, A Sharabi, Y Mina, A Klein, E Cagnano, O Elkayam, T Gurevich The Israel Medical Association Journal: IMAJ 18 (10), 630-632, 2016 | 3 | 2016 |
| Licensed medical cannabis use in Gilles de la Tourette syndrome: A retrospective long-term follow-up S Anis, C Zalomek, AD Korczyn, S Lassman, A Rosenberg, T Gurevich Cannabis and Cannabinoid Research 9 (3), e878-e885, 2024 | 2 | 2024 |
| Are LRRK2 p. G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease? S Anis, T Goldberg, E Shvueli, Y Kozlov, Y Redlich, N Lavi, I Lavie, ... Parkinsonism & Related Disorders, 106008, 2024 | 2 | 2024 |
| Atypical duration of epileptic and psychogenic nonepileptic events S Anis, F Fahoum, AD Korczyn, D Sverdlov, S Abramovici, Y Mina, ... Epilepsy & Behavior 111, 107145, 2020 | 2 | 2020 |
| Direct Electrophysiological Imaging, Analyzing Brain-induced Magnetic Stimulation Response, for the Diagnosis and Indication of Ventriculoperitoneal Shunting in Patients with … T Davidy, S Anis, A Suminski, Y Zauberman, T Fay-Karmon, ... Neurology 100 (17_supplement_2), 4310, 2023 | 1 | 2023 |
| Validation of the hebrew version of the unified dyskinesia rating scale A Faust-Socher, S Anis, M Kestenbaum, H Shabtai, T Taichman, ... Neuroepidemiology 54 (4), 356-362, 2020 | 1 | 2020 |
| Gene Expression Biomarkers for IFN-β Treatment Response in Relapsing-Remitting Multiple Sclerosis (P05. 143) S Anis, P Sonis, E Hanael, M Gurevich, A Achiron Neurology 80 (7_supplement), P05. 143-P05. 143, 2013 | 1 | 2013 |
| Should antinuclear antibodies (ANA) be used to screen for connective tissue disease in neurological patients? E Magiel, Y Kozlov, T Goldberg, R Loebenstein, A Watad, O Gendelman, ... Journal of the Neurological Sciences 469, 123374, 2025 | | 2025 |
| Correspondence regarding “Letter to the editor: TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome” S Anis Parkinsonism & Related Disorders, 2025 | | 2025 |
| Differences and contributors to global cognitive performance in the underrepresented Latinx Parkinson’s disease population S Anis, HM Chaparro-Solano, T Peixoto Leal, SA Sperling, C Sonneborn, ... The Clinical Neuropsychologist, 1-21, 2025 | | 2025 |
| TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome S Lassman, N Zifman, H Fogel, S Hassin-Baer, S Anis Parkinsonism & related disorders 130, 107217, 2025 | | 2025 |
| Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease-What is missing? A systematic review HM Chaparro-Solano, MR Paz, S Anis, JK Hockings, A Kundrick, ... Parkinsonism & Related Disorders, 107206, 2024 | | 2024 |
Sharon Hassin-BaerNeurologist, movement disorders specialist; director, Movement Disorders Institute, Sheba Medical在 tauex.tau.ac.il 的电子邮件经过验证
